Bharat Biotech's nasal Covid vaccine for adults gets Centre's nod
Vaccine to be available in private hospitals and will be included in vaccination programme
Stay updated with breaking news from Restricted Use. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Vaccine to be available in private hospitals and will be included in vaccination programme
Covaxin, India's first indigenous vaccine for Covid-19, was recently hit by a row with allegations that external pressure to deliver the jab quickly forced vaccine-maker Bharat Biotech to skin certain processes and expedite clinical trials.The ...
The company is currently holding discussions with international 'potential partners' who have approached the company for manufacturing and distribution of the intranasal vaccine globally
Bharat Biotech has requested the central government to include iNCOVACC in CoWIN portal to enable its recipients to get vaccination certificates easily.
New Nasal Vaccine to Fight COVID-19: World's first intranasal vaccine for COVID-19, iNCOVACC (BBV154), gets approval from the Central Drugs Standard Control Organization (CDSCO).